Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: A TH2 immunological mechanism

Toxicology

Volumn 118, Issue 1, 1997, Pages 61-70

  Del Pozo, Victoria ^a   De Andrés, Belén ^a   Gallardo, Soledad ^a   Cárdaba, Blanca ^a   De Arruda Chaves, Erika ^a   Cortegano, María Isabel ^a   Jurado, Aurora ^a   Palomino, Pilar ^a   Oliva, Horacio ^a   Aguilera, Beatriz ^a   Posada, Manuel ^b   Lahoz, Carlos ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b REUNI   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

Author keywords

Cytokines; Lung tissues; Th2 mechanism; Toxic oil syndrome

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOTOXICITY; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TOXIC OIL SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANILINE COMPOUNDS; BRASSICA; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE OUTBREAKS; EOSINOPHILIA; FEMALE; FOOD POISONING; GENE EXPRESSION; HUMANS; LUNG; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLANT OILS; RNA, MESSENGER; SPAIN; SYNDROME; TH1 CELLS; TH2 CELLS;

SINAPIS ARVENSIS; TOSCANA VIRUS;

EID: 0031567164     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(96)03584-6     Document Type: Article

References (37)

1. Cheng, T.O. (1993) Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome (letter). Mayo Clin. Proc. 68, 823-824.
2. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
3. Clauw, D.J., Zackrison, L.H. and Katz, P. (1992) Serum cytokines and the eosinophilia myalgia syndrome. (Letter) J. Int. Med. 117(4), 344-345.
4. De Andrés, B., del Pozo, V., Gallardo, S., de Arruda-Chaves, E., Cárdaba, B., Martin-Orozco, E., Posada, M., Palomino, P. and Lahoz, C. (1995) Improved method for mRNA extraction from paraffin-embedded tissues. Biotechniques 18(1), 42-43.
5. Del Prete, G.F., De Carli, M., Almerigogna, F., Giudizi, M.G., Biagiotti, R. and Romagnani, S. (1993) Human IL-10 is produced by both type I helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 1-8.
6. Flores-Romo, L., Shields, J., Humbert, Y., Graber, P., Aubry, J.P., Gauchat, J.F., Ayala, G., Allet, B., Chavez, M., Bazin, H., Capron, M. and Bonnefoy, J.Y. (1993) Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261, 1038-1041.
7. Gallardo, S., del Pozo, V., Cárdaba, B., de Andrés, B., Martin-Orozco, E., Fernandez, J.C., Tramón, P., Posada, M., Abaitua, I., Palomino, P. and Lahoz, C. (1994) Immunological basis of toxic oil syndrome (TOS). Toxicology 93, 289-299.
8. Goldman, M., Druet, P. and Gleichmann, E. (1991) Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12(7), 223-227.
9. Gomez-Sanchez, M.A., Saenz, C., Gomez-Pajuelo, C., Martinez-Tello, F.J., Mestre, M.J. and James, T.N. (1991) Clinical and pathologic manifestations of pulmonary vascular disease in the Toxic Oil Syndrome. J. Am. Coll. Cardiol. 18, 1539-1545.
10. Gordon, J. (1991) CD23: novel disease marker with a split personality. Clin. Exp. Immunol. 86, 356-359.
11. Grandjean, E.C. (1992) Toxic Oil Syndrome. Current knowledge and future perspectives. Introduction. WHO Reg. Publ. Eur. Ser. 42, 1-4.
12. Gruber, B.L., White and Needleman, B. (1991) Interleukin-4 levels in the eosinophilia-myalgia syndrome. Am. J. Med. 91, 664-665.
13. Iñiguez, C., Escobar, H. and Jimenez-Escrig, A. (1994) Serum soluble interleukin-2 receptor in spanish toxic oil syndrome (letter). Muscle Nerve October, pp. 1228-1229.
14. Kapsenberg, M.L., Wierenga, E.A., Bos, J.D. and Jansen, H.M. (1991) Functional subsets of allergen-reactive human CD4+ T cells. Immunol. Today 12(11), 392-393.
15. Kaufman, L.D., Gruber, B.L., Gómez-Reino, J.J. and Miller, F. (1994) Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome. Arch. Dermatol. 130, 41-47.
16. Kilbourne, E.M., Rigau, J.G. and Heath, C.W. (1983) Clinical epidemiology of toxic-oil syndrome. N. Engl. J. Med. 309, 1408-1414.
17. Kilbourne, E.M., Bernert, J.T. and Posada, M. (1988) Chemical correlates of pathogenicity of oils related to the Toxic Oil Syndrome epidemic in Spain. Am. J. Epidemiol. 127, 1210-1227.
18. Kilbourne, E.M., Posada, M., Abaitua, I., Diez Ruiz-Navarro, M., Philen, R.M. and Falk, H. (1991) Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. J. Am. Coll. Cardiol. 18(3), 711-717.
19. Martin, P., Diaz, M.J. and Gomez, M.A. (1991) Persistence of respiratory abnormalities four years after the onset of toxic oil syndrome. Chest 100, 336-339.
20. Martinez, F.J., Navas, J.J. and Ricoy, J.R. (1982) Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Sapin. Virchows Arch. (A) 397, 261-285.
21. Matsai, M., Nuñez, R., Sachi, Y., Lynch, R.G. and Yodoi, J. (1993) Alternative transcripts of the human CD23/FcE RII. FEBS Lett. 335, 51-56.
22. Mayeno, A.N., Belongia, E.A., Lin, F., Lundy, S.K. and Gleich, G.J. (1992) 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?. Mayo Clin. Proc. 67, 1134-1139.
23. Moqbel, R. (1994) Eosinophils, cytokines, and allergic inflammation. Ann. N.Y. Acad. Sci. 725, 223-233.
24. Morley, J. and Colditz, I. (1989) Eosinophils in asthma. Proceedings of a Symposium held at Lucerne, Switzerland, December 1987, Academic Press, London, pp. 29-43.
25. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. and Coffman, R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136(7). 2348-2357.
26. Owen, W.F., Petersen, J., Sheff, D.M., Folkerth, R.D., Anderson, R.J., Corson, J.M., Sheffer, A.L. and Austen, K.F. (1990) Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc. Natl. Acad. Sci. USA 87, 8647-8651.
27. Philen, R.M. and Posada, M. (1993) Toxic oil syndrome and eosinophilia-myalgia syndrome. 8-10 May 1991, World Health Organization meeting report. Semin. Arthritis Rheum. 23(2), 104-124.
28. Philen, R.M. and Hill, R.H. (1993) 3-(phenylamino)alanine -a link between eosinophilia-myalgia syndrome and toxic oil syndrome? Mayo Clin. Proc. 68, 197-200.
29. Romagnani, S. (1991) Human Th1 and Th2 subsets: doubt no more. Immunol. Today 12(8), 256-257.
30. Scott, P. and Kaufman, S.H.E. (1991) The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12(10), 346-348.
31. Silver, R.M., Sutherland, S.E., Carreira, P. and Heyes, M.P. (1992) Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. J. Rheumatol. 19, 69-73.
32. Tabuenca, J.M. (1981) Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2, 567-568.
33. Tabuenca, J.M. (1984) Discovery of toxic oil syndrome as the cause of the epidemic. In: P. Grandjean and S. Tarkowski (Eds), Toxic Oil Syndrome: Mass Food Poisoning in Spain: Report of a WHO Meeting. Madrid, 21-25 March 1983, World Health Organization Regional Office for Europe, Copenhagen.
34. Ten, R.M., Kephart, G.M. and Posada, M. (1990) The participation of eosinophils in the toxic oil syndrome. Clin. Exp. Immunol. 82, 313-317.
35. WHO (1992) Toxic Oil Syndrome and Eosinophilia-Myalgia Syndrome. Clinical Aspects. Report on a Workshop, Stony Brook, New York. WHO Regional Office for Europe, Copenhagen, pp. 1-19.
36. Wright, D.K. and Manos, M.M. (1990) Sample Preparation from Paraffin-embedded Tissues. PCR Protocols: A Guide to Methods and Applications. Academic Press, New York, pp. 153-165.
37. Yanagihara, Y., Sarfati, M., Marsh, D., Nutman, T. and Delespesse, G. (1990) Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin. Exp. Allergy 20, 395-401.